Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Arctium lappa* chloroform extract is a non-polar fraction derived from the roots of the Burdock plant (*Arctium lappa* L.). This specific extract is often studied for its high concentration of lipophilic bioactive compounds, such as lignans (e.g., arctigenin and arctiin), which possess anti-inflammatory, antioxidant, and anti-atherosclerotic properties. In preclinical models, such as high-fat diet-induced atherosclerosis in quail, the chloroform extract has demonstrated protective effects by modulating lipid profiles and reducing vascular plaque formation. It is primarily used in ethnopharmacological research and as a component in dietary supplements rather than as a regulated pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on arctium lappa chloroform extract.